Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Lupin launches generic morphine sulfate tablets in US

Saturday, January 14, 2017

Pharma major Lupin today said it has launched in the US market its generic version of morphine sulfate ER tablets used for management of severe pain The company said it has launched the morphine sulfate ER Tablets in strengths of mg mg mg mg and...

Shionogi Announces Positive Top-Line Results For Cefiderocol Pivotal cUTI Clinical Trial

Friday, January 13, 2017

Shionogi Co Ltd has announced that cefiderocol S a novel siderophore cephalosporin in latestage development met the FDA prespecified primary endpoint for noninferiority vs imipenemcilastatin IPMCS in patients with serious complicated urinary tract i...

Harrington Discovery Institute and Alzheimer's Drug Discovery Foundation Expand Collaboration

Friday, January 13, 2017

Harrington Discovery Institute at University Hospitals in Cleveland Ohio and the Alzheimers Drug Discovery Foundation ADDF have expanded their collaboration to accelerate translation of innovative research efforts for Alzheimers disease Together the...

Kitov Pharmaceuticals Enters Immuno-Oncology Field Through Acquisition of TyrNovo

Friday, January 13, 2017

Kitov Pharmaceuticals Holdings Ltd an innovative biopharmaceutical company announced the expansion of its pipeline through the acquisition of a majority stake in TyrNovo Ltd a privately held developer of novel small molecules in the immunooncology th...

U.S. FDA Accepts Biologics License Application (BLA) for Mylan and Biocon's Proposed Biosimilar Trastuzumab

Thursday, January 12, 2017

Mylan NV and Biocon Ltd announced that the US Food and Drug Administration FDA has accepted Mylans biologics license application BLA for MYLO a proposed biosimilar trastuzumab for filing through the k pathway This product is a proposed biosimilar to...

Aralez Pharmaceuticals Announces Issuance Of Additional U.S. Patent For Yosprala

Thursday, January 12, 2017

Aralez Pharmaceuticals Inc a global specialty pharmaceutical company announced that the United States Patent and Trademark Office USPTO has issued a patent entitled Compositions and Methods for Delivery of Omeprazole Plus Acetylsalicylic Acid that co...

Maverick Therapeutics and Takeda Announce Five-year Collaboration to Advance T-Cell Engagement Therapies

Thursday, January 12, 2017

Maverick Therapeutics Inc an MPM Capital portfolio company and Takeda Pharmaceutical Company Limited announced today that they have entered a collaboration to develop Mavericks Tcell engagement platform created specifically to improve the utility of...

Valeant Pharmaceuticals To Sell Dendreon To Sanpower Group For $819.9 Million

Wednesday, January 11, 2017

Valeant Pharmaceuticals International Inc announced that its affiliate has entered into a definitive agreement to sell all of the outstanding equity interests in Dendreon Pharmaceuticals Inc Dendreon to the Sanpower Group Co Ltd one of the largest pr...

Chi-Med Initiates HMPL-523 Clinical Trials in Hematological Cancer in China

Wednesday, January 11, 2017

Hutchison China MediTech Limited announces that it has initiated a Phase I trial of its novel spleen tyrosine kinase Syk inhibitor HMPL in patients with hematological malignancies in China The first patient was dosed on December This study compleme...

ViraCyte Granted U.S. FDA Fast Track Designation for Viralym-C

Wednesday, January 11, 2017

ViraCyte LLC announced that the US Food and Drug Administration FDA has granted Fast Track designation for ViralymC ViraCytes T cell immunotherapy product designed to treat refractory cytomegalovirus CMV infections in patients following a stem cell t...